Study Showed New Episodes of Depression Delayed in People Taking C...( INDIANAPOLIS Dec. 10 /- New data sugg...),Health

INDIANAPOLIS, Dec. 10 /PRNewswire-FirstCall/ -- New data suggest that Cymbalta (duloxetine HCl) 60 mg to 120 mg once daily delayed the onset of a new episode of depression in patients who had previously responded to the medication and who had recurrent depressive disorder, defined in the study as those patients who experienced at least three depressive episodes in the previous five years, compared with placebo (p < .001). Results from the 52- week maintenance phase of the longest controlled duloxetine study completed to date were presented at a meeting of a major scientific society today.

Additionally, patients who were treated with duloxetine were less likely (p < .001) to experience a new episode of depression than those who received placebo (recurrence rates were 14.4 percent vs. 33.1 percent, respectively).

Previous research has shown that up to 85 percent of patients with depression will experience depressive recurrences.(i) The number of episodes,(ii) their duration(iii) and the presence of lingering depressive symptoms increase the risk of recurrence, or future episodes of depression.(iv)

In the placebo-controlled maintenance phase of the study that followed initial open-label acute and continuation treatment phases, the most common adverse events (those occurring in at least 5 percent of patients in any treatment group) were headache, insomnia, dizziness, fatigue, back pain, common cold and flu.

    Additional Study Findings
    -- Time to worsening of depressive symptoms was significantly longer
       (p = .006) in the duloxetine-treated group compared with the placebo-
       treated group.  This was defined as a 50 percent increase from baseline
       on the 17-item Hamilton Rating Scale for Depression (HAMD17) total
       score and a Clinical Global Impressions of Severity (CGI-S) score of 3
       or more at anytime during the maintenance phase.
    -- Patients
'/>"/>
SOURCE  Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 
Related medicine news :

1. Study finds selenium, vitamin E do not prevent prostate cancer
2. Study Finds Doctors Use of E-Prescribing Systems Linked to Formulary Data Can Boost Drug Cost Savings
3. Genetic Markers Identified for Alcohol Response in UCSF Gallo Study
4. University of Michigan, Blue Care Network Study Quantifies Health Care Savings of Regular Dental Care for Patients with Diabetes
5. New Study Disputes Ongoing Controversy Over Memory Screenings
6. Haemacures Human Fibrin Sealant Demonstrates Effectiveness in Skin Graft Fixation Proof-of-Concept Study for Burn Injury
7. Medical terms worry more people than lay terms, study finds
8. Boston University School of Medicine receives a grant to study chronic obstructive pulmonary disease
9. Body clock linked to diabetes and high blood sugar in new study
10. Self-Dosing Pain Medication Errors Too Common: Study
11. Study finds treatment fails to improve common form of heart failure